These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


141 related items for PubMed ID: 9986794

  • 1. Sp1 is involved in a protein kinase C-independent activation of human T cell leukemia virus type I long terminal repeat by 12-O-tetradecanoylphorbol-13-acetate.
    Torgeman A, Mor-Vaknin N, Aboud M.
    Virology; 1999 Feb 15; 254(2):279-87. PubMed ID: 9986794
    [Abstract] [Full Text] [Related]

  • 2. Sp1-p53 heterocomplex mediates activation of HTLV-I long terminal repeat by 12-O-tetradecanoylphorbol-13-acetate that is antagonized by protein kinase C.
    Torgeman A, Mor-Vaknin N, Zelin E, Ben-Aroya Z, Löchelt M, Flügel RM, Aboud M.
    Virology; 2001 Mar 01; 281(1):10-20. PubMed ID: 11222091
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Sp family members preferentially interact with the promoter proximal repeat within the HTLV-I enhancer.
    Wessner R, Yao J, Wigdahl B.
    Leukemia; 1997 Apr 01; 11 Suppl 3():10-3. PubMed ID: 9209281
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Triple synergism of human T-lymphotropic virus type 1-encoded tax, GATA-binding protein, and AP-1 is required for constitutive expression of the interleukin-5 gene in adult T-cell leukemia cells.
    Yamagata T, Mitani K, Ueno H, Kanda Y, Yazaki Y, Hirai H.
    Mol Cell Biol; 1997 Aug 01; 17(8):4272-81. PubMed ID: 9234684
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. CCAAT/enhancer-binding proteins modulate human T cell leukemia virus type 1 long terminal repeat activation.
    Grant C, Nonnemacher M, Jain P, Pandya D, Irish B, Williams SC, Wigdahl B.
    Virology; 2006 May 10; 348(2):354-69. PubMed ID: 16458341
    [Abstract] [Full Text] [Related]

  • 18. Transcriptional activation of the human T-lymphotropic virus type I long terminal repeat by functional interaction of Tax1 and Ets1.
    Gitlin SD, Dittmer J, Shin RC, Brady JN.
    J Virol; 1993 Dec 10; 67(12):7307-16. PubMed ID: 8230454
    [Abstract] [Full Text] [Related]

  • 19. Twenty-one base pair repeat elements influence the ability of a Gal4-Tax fusion protein to transactivate the HTLV-I long terminal repeat.
    Connor LM, Oxman MN, Brady JN, Marriott SJ.
    Virology; 1993 Aug 10; 195(2):569-77. PubMed ID: 8337832
    [Abstract] [Full Text] [Related]

  • 20. A new regulatory element that augments the Tax-dependent enhancer of human T-cell leukemia virus type 1 and cloning of cDNAs encoding its binding proteins.
    Tanimura A, Teshima H, Fujisawa J, Yoshida M.
    J Virol; 1993 Sep 10; 67(9):5375-82. PubMed ID: 8350401
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.